Read More Healthcare Industry News Revance Therapeutics stock soars 16% as Teoxane proposes $360m deal Teoxane S.A., a global leader in the medical aesthetics sector based in Geneva, Switzerland, has made a bold… byPallavi MadhirajuJanuary 7, 2025